Carregant...
Recent progress in mapping the emerging landscape of the small-cell lung cancer genome
Small-cell lung cancer (SCLC) remains the deadliest of all the lung cancer types. Its high mortality is largely attributed to the invariable development of resistance to standard chemo/radiotherapies, which have remained unchanged for the past 30 years, underscoring the need for new therapeutic appr...
Guardat en:
| Publicat a: | Exp Mol Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906379/ https://ncbi.nlm.nih.gov/pubmed/31827074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-019-0349-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|